(Q44543451)

4 December 2017

Effect of sequencing of androgen deprivation and radiotherapy on prostate cancer growth (English)

1 reference

4 December 2017

1 reference

Joseph M L Kaminski

1

1 reference

4 December 2017

Alexandra L Hanlon

2

1 reference

4 December 2017

Daryl Lim Joon

3

1 reference

4 December 2017

Marvin Meistrich

4

1 reference

4 December 2017

Paul Hachem

5

1 reference

4 December 2017

Alan Pollack

6

1 reference

4 December 2017

language of work or name

English

0 references

publication date

1 September 2003

1 reference

International Journal of Radiation Oncology Biology Physics

4 December 2017

1 reference

4 December 2017

57

1 reference

4 December 2017

24-28

1 reference

4 December 2017

1

1 reference

Management of unfavorable locoregional prostate carcinoma with radiation and androgen ablation

4 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900539-X

7 January 2021

After radiotherapy testosterone stimulation is unable to increase growth in the dunning R3327-PAP prostate tumour

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900539-X

7 January 2021

Updated results of the phase III Radiation Therapy Oncology Group (RTOG) trial 85-31 evaluating the potential benefit of androgen suppression following standard radiation therapy for unfavorable prognosis carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900539-X

7 January 2021

Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and Goserelin

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900539-X

7 January 2021

Combined orchiectomy and external radiotherapy versus radiotherapy alone for nonmetastatic prostate cancer with or without pelvic lymph node involvement: a prospective randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900539-X

7 January 2021

Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900539-X

7 January 2021

The early supra-additive apoptotic response of R3327-G prostate tumors to androgen ablation and radiation is not sustained with multiple fractions

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900539-X

7 January 2021

Lack of prostate cancer radiosensitization by androgen deprivation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900539-X

7 January 2021

Posttreatment prostate-specific antigen nadir highly predictive of distant failure and death from prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900539-X

7 January 2021

Natural history of progression after PSA elevation following radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900539-X

7 January 2021

Determinants of prostate cancer-specific survival after radiation therapy for patients with clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900539-X

7 January 2021

Kinetics of serum prostate-specific antigen after external beam radiation for clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900539-X

7 January 2021

10.1016/S0360-3016(03)00539-X

Identifiers

DOI

1 reference

release_75yrwunpzjerxofz3ied43w5hi

4 December 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/75yrwunpzjerxofz3ied43w5hi

24 November 2022

mapped directly with Wikidata item

1 reference